An improved permeabilization protocol for the introduction of peptides into cardiac myocytes: Application to protein kinase C research

John A Johnson, Mary O. Gray, Joel S. Karliner, Che Hong Chen, Daria Mochly-Rosen

Research output: Contribution to journalArticle

77 Citations (Scopus)

Abstract

We have developed an improved, less disruptive procedure for the transient permeabilization of neonatal cardiac myocytes using saponin. The method allows delivery of peptides to a high percentage of cells in culture without effects on long-term cell viability. Permeation was confirmed microscopically by cellular uptake of a fluorescently labeled peptide and biochemically by uptake of 125I-labeled calmodulin and a 20-kD protein kinase Cε fragment into the cells. The intracellular molar concentration of the introduced peptide was ≃10% of that applied outside. We found no significant effects of permeabilization on spontaneous, phorbol ester- modulated, or norepinephrine-modulated contraction rates. Similarly, the expression of c-fos mRNA (measured 30 minutes after permeabilization) and the incorporation of [14C]phenylalanine following agonist stimulation (measured 3 days after permeabilization) were not altered by saponin permeabilization. Finally, permeabilization of cells in the presence of a protein kinase C pseudosubstrate peptide, but not a control peptide, inhibited phorbol ester- induced [14C]phenylalanine incorporation into proteins by 80%. Our results demonstrate a methodology for the introduction of peptides into neonatal cardiac myocytes that allows study of their actions without substantial compromises in cell integrity.

Original languageEnglish (US)
Pages (from-to)1086-1099
Number of pages14
JournalCirculation Research
Volume79
Issue number6
DOIs
StatePublished - Jan 1 1996
Externally publishedYes

Fingerprint

Cardiac Myocytes
Protein Kinase C
Peptides
Research
Saponins
Phorbol Esters
Phenylalanine
Calmodulin
Cell Survival
Norepinephrine
Cell Culture Techniques
Messenger RNA
Proteins

Keywords

  • contraction
  • hypertrophy
  • neonatal cardiac myocytes
  • permeabilization method
  • protein kinase C

ASJC Scopus subject areas

  • Physiology
  • Cardiology and Cardiovascular Medicine

Cite this

An improved permeabilization protocol for the introduction of peptides into cardiac myocytes : Application to protein kinase C research. / Johnson, John A; Gray, Mary O.; Karliner, Joel S.; Chen, Che Hong; Mochly-Rosen, Daria.

In: Circulation Research, Vol. 79, No. 6, 01.01.1996, p. 1086-1099.

Research output: Contribution to journalArticle

Johnson, John A ; Gray, Mary O. ; Karliner, Joel S. ; Chen, Che Hong ; Mochly-Rosen, Daria. / An improved permeabilization protocol for the introduction of peptides into cardiac myocytes : Application to protein kinase C research. In: Circulation Research. 1996 ; Vol. 79, No. 6. pp. 1086-1099.
@article{f5b9410b5b15410e852356cc0361bcfa,
title = "An improved permeabilization protocol for the introduction of peptides into cardiac myocytes: Application to protein kinase C research",
abstract = "We have developed an improved, less disruptive procedure for the transient permeabilization of neonatal cardiac myocytes using saponin. The method allows delivery of peptides to a high percentage of cells in culture without effects on long-term cell viability. Permeation was confirmed microscopically by cellular uptake of a fluorescently labeled peptide and biochemically by uptake of 125I-labeled calmodulin and a 20-kD protein kinase Cε fragment into the cells. The intracellular molar concentration of the introduced peptide was ≃10{\%} of that applied outside. We found no significant effects of permeabilization on spontaneous, phorbol ester- modulated, or norepinephrine-modulated contraction rates. Similarly, the expression of c-fos mRNA (measured 30 minutes after permeabilization) and the incorporation of [14C]phenylalanine following agonist stimulation (measured 3 days after permeabilization) were not altered by saponin permeabilization. Finally, permeabilization of cells in the presence of a protein kinase C pseudosubstrate peptide, but not a control peptide, inhibited phorbol ester- induced [14C]phenylalanine incorporation into proteins by 80{\%}. Our results demonstrate a methodology for the introduction of peptides into neonatal cardiac myocytes that allows study of their actions without substantial compromises in cell integrity.",
keywords = "contraction, hypertrophy, neonatal cardiac myocytes, permeabilization method, protein kinase C",
author = "Johnson, {John A} and Gray, {Mary O.} and Karliner, {Joel S.} and Chen, {Che Hong} and Daria Mochly-Rosen",
year = "1996",
month = "1",
day = "1",
doi = "10.1161/01.RES.79.6.1086",
language = "English (US)",
volume = "79",
pages = "1086--1099",
journal = "Circulation Research",
issn = "0009-7330",
publisher = "Lippincott Williams and Wilkins",
number = "6",

}

TY - JOUR

T1 - An improved permeabilization protocol for the introduction of peptides into cardiac myocytes

T2 - Application to protein kinase C research

AU - Johnson, John A

AU - Gray, Mary O.

AU - Karliner, Joel S.

AU - Chen, Che Hong

AU - Mochly-Rosen, Daria

PY - 1996/1/1

Y1 - 1996/1/1

N2 - We have developed an improved, less disruptive procedure for the transient permeabilization of neonatal cardiac myocytes using saponin. The method allows delivery of peptides to a high percentage of cells in culture without effects on long-term cell viability. Permeation was confirmed microscopically by cellular uptake of a fluorescently labeled peptide and biochemically by uptake of 125I-labeled calmodulin and a 20-kD protein kinase Cε fragment into the cells. The intracellular molar concentration of the introduced peptide was ≃10% of that applied outside. We found no significant effects of permeabilization on spontaneous, phorbol ester- modulated, or norepinephrine-modulated contraction rates. Similarly, the expression of c-fos mRNA (measured 30 minutes after permeabilization) and the incorporation of [14C]phenylalanine following agonist stimulation (measured 3 days after permeabilization) were not altered by saponin permeabilization. Finally, permeabilization of cells in the presence of a protein kinase C pseudosubstrate peptide, but not a control peptide, inhibited phorbol ester- induced [14C]phenylalanine incorporation into proteins by 80%. Our results demonstrate a methodology for the introduction of peptides into neonatal cardiac myocytes that allows study of their actions without substantial compromises in cell integrity.

AB - We have developed an improved, less disruptive procedure for the transient permeabilization of neonatal cardiac myocytes using saponin. The method allows delivery of peptides to a high percentage of cells in culture without effects on long-term cell viability. Permeation was confirmed microscopically by cellular uptake of a fluorescently labeled peptide and biochemically by uptake of 125I-labeled calmodulin and a 20-kD protein kinase Cε fragment into the cells. The intracellular molar concentration of the introduced peptide was ≃10% of that applied outside. We found no significant effects of permeabilization on spontaneous, phorbol ester- modulated, or norepinephrine-modulated contraction rates. Similarly, the expression of c-fos mRNA (measured 30 minutes after permeabilization) and the incorporation of [14C]phenylalanine following agonist stimulation (measured 3 days after permeabilization) were not altered by saponin permeabilization. Finally, permeabilization of cells in the presence of a protein kinase C pseudosubstrate peptide, but not a control peptide, inhibited phorbol ester- induced [14C]phenylalanine incorporation into proteins by 80%. Our results demonstrate a methodology for the introduction of peptides into neonatal cardiac myocytes that allows study of their actions without substantial compromises in cell integrity.

KW - contraction

KW - hypertrophy

KW - neonatal cardiac myocytes

KW - permeabilization method

KW - protein kinase C

UR - http://www.scopus.com/inward/record.url?scp=0029846884&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0029846884&partnerID=8YFLogxK

U2 - 10.1161/01.RES.79.6.1086

DO - 10.1161/01.RES.79.6.1086

M3 - Article

C2 - 8943947

AN - SCOPUS:0029846884

VL - 79

SP - 1086

EP - 1099

JO - Circulation Research

JF - Circulation Research

SN - 0009-7330

IS - 6

ER -